My Photo

Blogs Tracked

Subscribe


  • Copy the following link to add SF Venture to your favorite news reader. (Click here for help.)

    Syndicate this site (XML)


    Select this button to add SF Venture to My Yahoo!:


    Enter your Email


    Powered by FeedBlitz

My Adroll

« Venture Exits Up In Q1:06 | Main | AIM Gaining Share »

July 07, 2006

Will the US IPO Market Ever Recover? Can AIM Provide A Viable Alternative?

Quarterly exit data has just been released by Thomson Venture Economics and the NVCA.  Although there was an increase in IPO activity, there overall trend remains flat. 

In the second quarter of 2006, 19 venture-backed IPOs raised a total of $2 billion, up significantly from both the first quarter of 2006 and the second quarter of 2005. 

M&A activity was $3.2 billion in Q1 of 2006.  There were a total of 86 M&A deals with 34 disclosing values.  Average disclosed deal value was $95 million in Q2 of 2006. These numbers are down somewhat sequentially and from last year.  Roughly 29% of those deals returned more than 4x the investment, 42% returned 1x-4x, and only 29% less than the amount invested.  It took almost 6 years on average between founding and M&A exit. 

Levels are still not high enough to provide venture funds returns in excess of competing asset classes, including buyouts and hedge funds. 

Three of these IPOs were US companies on foreign exchanges, 2 on London’s AIM (Alternative Investment Market) and 1 on the London Stock Exchange.  We are encouraged about what we’ve been learning about AIM, which could provide a reasonable alternative for venture-backed companies to go public. 

What is AIM?  It was created 11 years ago as an affiliate of the London Stock Exchange to list smaller companies.  The structure is friendly to smaller stocks.  UK investors receive tax benefits by holding long-term, discouraging the volatility typical on NASAQ.  Relative to NASDAQ, where Sarbanes Oxley makes disclosure problematic and expensive, disclosure rules on AIM are reasonable.  Given Spitzer’s hobbling of the research function, it’s impractical to list a company on NASDAQ with a market capitalization of less than $500 million.  AIM is geared to companies below $100 million.  Until recently, company sizes, exchange volumes, and international investor interest has been low to modest.   A few US technology companies have listed on AIM, allowing financing, but less trading liquidity than NASDAQ.  Liquidity for venture investors has been enabled more secondary offerings than open-market sales.  That appears to be changing, with activity increasing on AIM. 

We’ve wondered how venture-backed companies get large enough to get on NASDAQ.  Historically, NASDAQ’s structure supported more risk taking behavior, allowing companies with modest revenue levels to go public with growth stories, using IPO proceeds and the marketing event of on IPO to validate competitive positioning against larger legacy companies.  Over the last few years, we’ve observed most technology companies have struggled to scale businesses without the help of an IPO with buyers of technology cautious about dealing with private companies.  A few companies have crossed the marketing chasm by taking more time, raising more money privately or merging with other private companies.  If AIM can show it can market technology growth stories, AIM could provide a bridge between venture and NASDAQ, with successful companies achieving the scale needed to move over to NASDAQ.

Based on discussions with investment banks, we expect more US technology companies to list on AIM and will be monitoring trends in the market closely. 

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/t/trackback/279739/5271873

Listed below are links to weblogs that reference Will the US IPO Market Ever Recover? Can AIM Provide A Viable Alternative?:

Comments

I am involved with a "start-up" that has completed their SEC filing some months ago and that will be listed on the OTC/BB shortly. As all our operations are in Europe I am actively investigating if and how we can "transfer" our listing from the OTC/BB to AIM....

It looks like a good exchange for us and other companies in our position.

E.

Having been through an IPO on AIM as a former CEO of start-up pharma company Alltracel Pharmaceuticals Plc, and having worn out shoe leather in NYC and beyond in my quest for funds in the Dot.Com boom, it was a life saver.

For Irish and UK based VC's this has been a very successful means to access liquidity and there is continued growth in foreign corporations for this route to secondary funding and indeed IPO exit strategies.

It makes successful little (less than $100m) companies into bigger ones, rather than die in the wilderness. It has my vote for what I did and for what I have yet to do.

Gerard Brandon
Editor Guru Manager
http://www.gurumanager.com

This is a very important topic for all. The M&A market is good now, but the number of mid-tier buyers that often spark efforts are drying up. Check out the national research exchange, which is working on a part of the solution. www.researchexchange.com

Post a comment

Comments are moderated, and will not appear on this weblog until the author has approved them.

If you have a TypeKey or TypePad account, please Sign In